Financing type:   underwritten prospectus offering

Gross proceeds:  $20,002,250

Offering:   21,055,000 listed shares

Offering price:   95 cents per listed share

Overallotment option:  The underwriters may purchase a maximum of 3,158,250 listed shares for overallotment purposes. As of April 2, 2026, such option remains outstanding.

Public disclosure:  refer to the prospectus supplement dated March 27, 2026, and the company's news release(s) dated March 25, 2026, and April 2, 2026